Austedo 6 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FXTG5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,755
Award facts
- Contract value 100% obligated
- $29,754.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,754.54 to AmerisourceBergen Drug Corp for the supply of Austedo 6 mg tablets (60-count units) on January 8, 2026, with an ultimate completion date of January 9, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Austedo is a prescription medication indicated for the treatment of tardive dyskinesia, a neurological condition, and represents one of numerous pharmaceutical products that AmerisourceBergen supplies to federal healthcare systems through its extensive contract portfolio.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a separate IDC with the DLA valued at up to $999,999,999.00 extending through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. These arrangements enable AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a diverse range of medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FXTG5?
SPE2DR26FXTG5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FXTG5 worth?
The government has obligated $29,755 on SPE2DR26FXTG5.
Is contract SPE2DR26FXTG5 an order under another contract?
Yes. SPE2DR26FXTG5 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXTG5 competed?
The extent of competition for SPE2DR26FXTG5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award